Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Cytokinetics Inc (NASDAQ: CYTK) closed the day trading at $31.69 down -2.42% from the previous closing price of $32.48. In other words, the price has decreased by -$2.42 from its previous closing price. On the day, 1.04 million shares were traded.
Ratios:
For a better understanding of CYTK, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.99 and its Current Ratio is at 5.99.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on April 24, 2025, initiated with a Overweight rating and assigned the stock a target price of $55.
On February 07, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $86.
On January 22, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $80.Stifel initiated its Buy rating on January 22, 2025, with a $80 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 06 ’25 when Malik Fady Ibraham sold 2,000 shares for $35.01 per share. The transaction valued at 70,020 led to the insider holds 140,255 shares of the business.
Callos Andrew sold 4,002 shares of CYTK for $146,793 on May 05 ’25. The EVP, Chief Commercial Officer now owns 60,687 shares after completing the transaction at $36.68 per share. On Apr 29 ’25, another insider, Blum Robert I, who serves as the President & CEO of the company, sold 5,000 shares for $40.96 each. As a result, the insider received 204,800 and left with 417,629 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 196.95.
Stock Price History:
Over the past 52 weeks, CYTK has reached a high of $68.44, while it has fallen to a 52-week low of $31.67. The 50-Day Moving Average of the stock is -21.93%, while the 200-Day Moving Average is calculated to be -35.43%.
Shares Statistics:
A total of 119.22M shares are outstanding, with a floating share count of 116.28M. Insiders hold about 2.63% of the company’s shares, while institutions hold 112.16% stake in the company.
